ENDOMETRIOSIS DIAGNOSIS

Why does receiving a diagnosis for endometriosis take so long?

Why does receiving a diagnosis for endometriosis take so long?

There are multiple factors that contribute to an average endometriosis diagnosis taking eight years.

 

Endometriosis is a chronic condition that can cause intense pain in several circumstances, including during menstruation and sexual intercourse.

 

I​t can be challenging for some people to receive a prompt diagnosis of endometriosis.

 

Recent research found that several factors can delay an endometriosis diagnosis by as much as 11 years due to personal and societal barriers and the actions and training of healthcare professionals.

 

A​ recent systematic review and qualitative synthesis examined why receiving a prompt diagnosis of endometriosis is difficult.

 

The researchers identified several factors, including the normalization of menstrual pain, the diversity of symptoms, and a lack of training and prompt referrals among healthcare professionals.

 

The review sheds light on areas for improvement in the prompt diagnosis and, thus, treatment of endometriosis.

 

The study is published in Obstetrics and Gynecology.

 

The impact of endometriosis

 

Endometriosis is a condition in which uterine-like tissue grows outside of the uterus. These lesions can be present in several areas, including the ovaries, fallopian tubes, or bladder.

 

Endometriosis is chronic, and treatment mainly focuses on managing symptoms. The main symptom is pain, often in the pelvic area. The pain may occur at specific times, such as during menstruation. There may also be other symptoms, such as difficulty getting pregnant and fatigue. The symptoms of endometriosis may sometimes improve after menopause.

 

Dr. Ann Peters, an obstetric and gynecology specialist at Mercy Medical Center, who was not involved in the study, offered further insight into endometriosis to Medical News Today:

 

“[Endometriosis] is also a[n] extremely debilitating chronic disease that presents most commonly with painful periods but also a number of other complaints such as pain with intercourse, pain with bowel movements, diarrhea, constipation, urinary symptoms such as urinary frequency and urgency, heavy periods, chest pains, and chronic fatigue.”

 

“[One] out of 10 women are estimated to have endometriosis, but it is sometimes difficult to make the diagnosis because there currently are no noninvasive diagnostic modalities such as ultrasound or blood work testing that will reliably diagnose endometriosis.”

— Dr. Ann Peters

 

Researchers of the current review note that many women experience a delay in receiving an accurate medical diagnosis. They wanted to understand more about why this delay occurs.

 

 

Barriers to an endometriosis diagnosis

T​his review included 13 articles that met strict eligibility criteria. All the studies included either women with endometriosis or healthcare professionals who had experience diagnosing endometriosis.

 

The review specifically focused on qualitative studies where participants shared their views on the journey of receiving an endometriosis diagnosis. Based on an analysis of these articles, the authors identified themes that fell into four categories contributing to delayed diagnosis:

 

Individual factors

Interpersonal influences

Health system factors

F​actors specific to endometriosis

 

A​t the individual level, they found that women struggled with understanding typical menstruation pain. For example, there was a common assumption among participants that the pain was typical and that they just had to deal with it. These ideas and the use of self-care measures to manage symptoms likely influenced the time of endometriosis diagnosis.

 

A​t the interpersonal level, researchers found that stigma surrounding discussing menstrual problems and society viewing menstrual pain as normal may have further contributed to delayed diagnosis.

 

Finally, healthcare and endometriosis factors influenced diagnosis timing. For example, participants reported general practitioners brushing aside concerns or appearing to lack knowledge about endometriosis. Similarly, healthcare professional participants also expressed inadequate training regarding endometriosis, and many noted they also lacked clear clinical guidelines for diagnosis.

 

There were further problems in communication. Healthcare professionals sometimes use oral contraceptives to aid in diagnosing and treating endometriosis. Participants did not always receive clear explanations of ruling out other diagnoses or the strategy behind oral contraceptive use.

 

Lack of tests for endometriosis

Healthcare professionals further noted that symptoms of endometriosis can overlap with symptoms of other conditions, making delays in diagnosis possible. Endometriosis is also challenging to diagnose because there aren’t noninvasive tests that can give an accurate diagnosis. There were delays in referrals.

 

One reason for this was the misconception that laparoscopic surgery is the only means of diagnosis. Healthcare professionals also had doubts about the usefulness of an endometriosis diagnosis.

 

Study author Dr. Sophie Davenport, a doctor in England who conducted this research as part of a dissertation in Public Health (MPH), explained how the approach to overcoming these barriers will need to happen on many levels:

 

“The key highlights of the data are that delays to diagnosis exist throughout the journey. We need to target these at different levels – from society recognising what ‘normal’ menstruation is and being open to discussing menstrual problems, to clinicians being well-educated and up to date on the presentation and diagnosis and listening to patients when they say their periods aren’t normal.”

— Dr. Sophie Davenport, study author

 

Investigating the experience of endometriosis diagnosis

This research did have limitations that indicate the need for further research.

 

The studies included in the review were all conducted in high-income countries, and most of these countries had universal healthcare. Thus, it may not be possible to generalize the results, and this review doesn’t address financial barriers that may influence diagnosis.

 

Among studies that reported demographics, most participants were white women, indicating the need for more diversity in further research.

 

Among participants with endometriosis, the samples may be skewed toward those with more severe endometriosis.

 

In the studies that looked at the views of healthcare professionals, participants were doctors and mainly general practitioners. Further research could include other providers and specialists in the analysis. Finally, one reviewer conducted the review, introducing more risk for bias or method errors.

 

D​r. Davenport noted the following focus of continued research:

 

“A key area of research will be to investigate how [a] patient’s experiences of receiving a diagnosis of endometriosis change now that the clinical guidelines recommend treating empirically based on signs and symptoms, rather than a laparoscopic surgery being first-line. It was suggested in the papers that this deterred clinicians from referring women to specialist services and delayed women receiving a diagnosis and subsequent treatment.”

— D​r. Sophie Davenport

 

Speaking out about endometriosis symptoms is important

 

For those who think they may have endometriosis, seeking medical help is critical. This may include talking with a general practitioner. Dr. Davenport hoped their research would help encourage people and healthcare professionals to strive for prompt diagnosis.

 

“We would hope that the paper encourages patients to seek help if they feel that their periods are abnormal or causing them significant pain or distress, and [that it] encourages clinicians to take their concerns seriously and refer to specialist services early,” she said.

 

D​r. Peters further noted that women with endometriosis can support others and continue to raise awareness of the condition.

 

https://journals.lww.com/greenjournal/Abstract/9900/Barriers_to_a_Timely_Diagnosis_of_Endometriosis__A.821.aspx

 

Source: https://www.medicalnewstoday.com/articles/why-does-receiving-diagnosis-endometriosis-take-so-long

 

How new endometriosis guidelines will improve diagnosis, treatment

How new endometriosis guidelines will improve diagnosis, treatment

Endometriosis is a condition in which tissue similar to the lining inside the uterus grows outside the uterus. It affects around 190 million — or 10% — of women and girls of reproductive age worldwide.

 

Although some people with endometriosis are asymptomatic, common symptoms include:

 

  • painful cramping, similar to menstrual cramps
  • long-term lower back and pelvic pain
  • abnormal periods
  • bowel and urinary problems, including pain, diarrhea, constipation, and bloating
  • blood in the stool or urine
  • nausea and vomiting
  • fatigue
  • pain during intercourse
  • spotting or bleeding between periods
  • infertility

 

While this is a common condition, people often only receive a diagnosis for it 8-12 years after symptom onset. More specific guidelines could improve diagnosis and treatment for people with the condition.

 

In a recent report, the European Society of Human Reproduction and Embryology (ESHRE) developed new clinical practice guidelines for diagnosing and treating endometriosis.

 

“These guidelines offer better ways to manage and treat endometriosis for physicians and hope and comfort for millions of women who have felt frustrated and desperate by this debilitating disease,” Dr. Sherry Ross, OB/GYN and Women’s Health Expert at Providence Saint John’s Health Center in Santa Monica, CA, told Medical News Today.

 

Major changes

 

Diagnosis

 

In the previous 2014 guidelines, laparoscopy — a surgical procedure involving small incisions in the abdomen to insert a camera — was considered the gold standard diagnostic tool.

 

Due to recent advancements in imaging modalities, operative risk, limited access to highly-qualified surgeons, and financial implications, the ESHRE now only recommends laparoscopy if imaging results are negative and treatments unsuccessful or inappropriate.

 

Pain treatment

 

The present guidelines now recommend GnRH agonist or GnRH antagonist treatments — which prevent the ovaries from making sex hormones by desensitizing the pituitary gland — as a second-line treatment option.

 

They also say that NSAIDs may aid postoperative pain, the guidelines note that this may affect conception if taken continuously.

 

Infertility treatment

Extended use of GnRH agonists before assisted reproduction techniques (ARTs) — including in vitro fertilization — is no longer recommended to increase fertility due to unclear benefits.

 

Meanwhile, the Endometriosis Fertility Index (EFI) was added as a treatment step to help patients decide how to achieve pregnancy postsurgery.

 

Recurrence

 

The current guidelines recommend hormone treatments, including combined hormonal contraceptives for at least 18-24 months after surgery to prevent a recurrence.

 

They add that ART does not increase recurrence in women with deep endometriosis — a single nodule larger than 1 centimeter (cm) in diameter outside the uterus or close to the lower 20 cm of the bowel.

 

In conversation with MNT, Dr. Yen Hope Tran, OB/GYN at MemorialCare Orange Coast Medical Center in Fountain Valley, CA, noted that the guidelines also recommend surgeons “perform cystectomy instead of drainage and coagulation, as cystectomy reduces recurrence of endometrioma and endometriosis-associated pain.”

 

Adolescence

 

“Often, endometriosis manifests in adolescence, even early adolescence, but teens are unlikely to know that their pain and other symptoms are not the norm,” said Dr. Tran. “Period pain during this time is not normal.”

 

“Teens and their physicians often don’t address endometriosis — or endo symptoms — in the few meetings they are likely to have. I find it useful to ask about them having to miss classes/skip school because of their symptoms,” she added.

 

When diagnosing and treating adolescents, the guidelines recommend clinicians carefully investigate possible risk factors for endometriosis, including positive family history, obstructive genital malformations, early first menstruation, and a short menstrual cycle.

 

To treat endometriosis in adolescents, they recommend hormonal contraceptives or progesterone as first-line hormone therapy.

 

The American College of Obstetricians and Gynecologists recommends NSAIDs as the mainstay of pain relief for adolescents with endometriosis.

 

The World Health Organization (WHO) also recommends that if GnRH agonists are considered for adolescents and young women, the potential side effects and long-term health risks should first be discussed with a clinician in a secondary or tertiary setting.

 

“[The guidelines emphasize] preservation of fertility. Adolescents with endometriosis should be informed of the risk of becoming infertile so that they can make a more informed decision about early surgical intervention, preservation of oocytes, and other steps should they ever want to have children,” said Dr. Tran.

 

The ESHRE hopes that the new guidelines will assist both patients and healthcare professionals in better understanding and dealing with endometriosis.

 

When asked what the main points are for patients and clinicians to be aware of from these guidelines, Dr. Tran said:

 

Endometriosis is a serious disease. It causes perhaps as much as 50% of all cases of infertility [and] each case is different. Any correlation between getting pregnant and experiencing relief of endometriosis symptoms are regarded as rare, and amount to wishful thinking.”

 

“Endometriosis recurs quite frequently, and no one treatment is appropriate for every patient or every case. Later in life, different treatments may be called for. You’re never out of the woods with endometriosis. Damage from endo continues to cause problems for women even after menopause,” she explained.

 

“Talk to your doctor, don’t put off treatment. Relief from symptoms is possible. Preservation of fertility needs to start immediately; endometriosis is serious and should be taken seriously,” she concluded.

 

 

https://academic.oup.com/hropen/article/2022/2/hoac009/6537540

First endometriosis blood test detects up to 9 out of 10 cases

First endometriosis blood test detects up to 9 out of 10 cases

 Endometriosis is notoriously difficult to diagnose. A recent study showed that it usually takes 7-12 years from first experiencing symptoms to diagnosis.

A private company (MDNA Life Sciences) announced that it is to launch the world’s first blood test for endometriosis, able to detect the disease in up to 9 out of 10 cases. Results will be available in a matter of days after the test is carried out, enabling doctors to make earlier decisions on diagnosis and treatment.

Endometriosis, a debilitating condition affecting 1 in 10 women of reproductive age, causes years of pain and distress. A surgical procedure is required to definitively diagnose the condition, resulting in an average delay to diagnosis of 7.5 years.

Using its proprietary technology, MDNA has developed techniques to exploit the unique characteristics of mutations in mitochondrial DNA, which can act as biomarkers for the presence of a range of diseases.

After successfully identifying biomarkers for different types of cancer, researchers at MDNA’s Newcastle upon Tyne laboratory have now identified biomarkers associated with endometriosis. Results of a clinical study recently published in the peer-reviewed journal Biomarkers in Medicine, show that the newly identified biomarkers can accurately detect endometriosis in blood samples in up to 9 out of 10 cases, even in its early stages.

MDNA has now embarked on a programme to create a CE-marked test kit to enable clinical laboratories in the UK and worldwide to carry out the test on a commercial basis. The CE process will be completed in 9-10 months.

Dr Andrew Harbottle, MDNA Life Sciences’ Chief Science Officer explains: “Mutations in mitochondrial DNA act as ideal biomarkers, providing us with a unique and detailed diary of damage to the DNA and accurately detecting many difficult to diagnose diseases and conditions, such as endometriosis”.

MDNA’s Mitomi Technology platform identifies and optimises the best biomarkers to detect a specific disease. The company has already demonstrated the accuracy of its technology in a blood test for prostate cancer. As well as the new test for endometriosis, MDNA is planning to release tests for ovarian cancer and pancreatic cancer next year. Tests for lung, liver, and stomach cancers will follow in 2021 and more tests are in the pipeline.

Harry Smart, MDNA Life Sciences’ Chairman says “Our ground-breaking test for endometriosis will fundamentally change the way this debilitating disease is detected and diagnosed. We look forward to helping women get treatment sooner, reducing their pain and distress and providing cost savings to health services”.

My opinion

The development of a reliable non-invasive test for the diagnosis of endometriosis is highly desirable and necessary since it will spare many patients of unnecessary surgical interventions and it will facilitate and speed up the diagnosis and management of endometriosis. This will immensely improve the quality of life of millions of women worldwide.

Source:

https://mdnalifesciences.com/2019/04/worlds-first-blood-test-for-endometriosis-can-detect-up-to-9-out-of-10-cases/

Endometriosis diagnosis takes 7 to 12 years

Endometriosis diagnosis takes 7 to 12 years

Endometriosis may affect all aspects of a woman’s life, including sexual relations, social activities, emotional well-being and work productivity.

The disease is costly. Claims data show that average annual health care costs (medical and prescription) are more than three times higher for women with endometriosis compared to patients without endometriosis, even five years pre- and five years post-diagnosis. Τhe cost can increase in cases of greater severity of the disease, presence of pelvic pain and infertility.

However, endometriosis is still underfunded and under-researched, thus limiting scientific progress and the number of available diagnostic and treatment options, according to a new review study.

Aiming to address these concerns, the Society for Women’s Health Research (SWHR) brought together a group of researchers, clinicians, and patients as well as industry and government officials, who evaluated barriers affecting endometriosis diagnosis and treatment, reviewed current practice, and highlighted research priorities.

Multidisciplinary approaches addressing all patient needs and greater disease awareness are needed to improve care, diagnosis and development of treatments for people with endometriosis, showed the resutls of the research “Assessing Research Gaps and Unmet Needs in Endometriosis,” which was published in the American Journal of Obstetrics and Gynecology.

According to the expert group, the current lack of knowledge and awareness about the causes of endometriosis contributes to the significant delays (7 to 12 years) from first experiencing symptoms to diagnosis. These delays are even worse for women with pelvic pain and for younger women, and may cause physical and emotional damage, as well as increase costs associated with the disease.

Another contributing factor is that the current gold standard for diagnosis requires surgery (laparoscopy), warranting the development of accurate, noninvasive and less costly diagnostic tools, such as biomarkers. Also, current guidelines only recommend assessing endometrial lesions, despite reports of a questionable association between the number of lesions and disease severity, symptoms and impact on women’s quality of life.

Campaigns to educate patients, healthcare providers, and the public may also help achieve more timely and accurate diagnosis and treatment, the team noted.

Additional barriers are difficulties with insurance coverage, and the stigma around menstrual issues and society’s normalization of women’s pain, which may make patients reluctant to discuss symptoms or seek care.

“In addition, women who do bring up their symptoms may fall victim to the well-documented clinical gender bias that has resulted in some women’s pain being dismissed or inadequately treated,” Rebecca Nebel, PhD, the study’s senior author and director of scientific programs at SWHR, said.

Standardized screenings, such as those used in cases of potential violence against women, could be used as a model in endometriosis, the experts said.

Other barriers are related to healthcare providers, as women need to make an average of seven visits to their primary provider before being referred to specialists, and often are misdiagnosed.

As for current practice in treatment, most medical and surgical approaches — including hysterectomy and uterus removal — focus on managing pain and associated symptoms by suppressing or removing endometrial lesions, but may not be effective.

Physical therapy, acupuncture, and yoga are examples of non pharmacological strategies that may help ease pain. Mental health professionals may help treat depression and grieving associated with endometriosis, while also providing coping and relaxation strategies.

Available medical therapies may induce side effects such as bone loss, hot flashes, and weight gain. Also, many cannot be used when women are trying to get pregnant, often forcing them to decide on whether to minimize pain or time their attempts to conceive while off medication.

Overall, “future treatments and care should shift toward a patient-centric, multidisciplinary approach that focuses on the patient as a whole, rather than one symptom at a time,” the experts said.

Centers of expertise taking an interdisciplinary approach with experts in “laparoscopy, medical management, pain education, physical therapy, and psychological care” may help implement treatment strategies “that address all the needs of the patient, including quality-of-life issues,” the team stated.

Read more: https://www.ajog.org/article/S0002-9378(19)30385-0/pdf

https://www.ajog.org/article/S0002-9378(19)30385-0/fulltext

Source: https://endometriosisnews.com/2019/02/28/multidisciplinary-approach-awareness-will-most-benefit-endometriosis-patients-experts-say/

Endometriosis can also affect adolescents

Endometriosis can also affect adolescents

By I.Soussis MD

Although endometriosis is commonly characterized as a disease affecting adult women of reproductive age, a review article compiled by an international panel of experts and published in Best Practice & Research Clinical Obstetrics and Gynaecology highlighted that it can also affect adolescents and younger women.

In addition, the authors reported that many women may experience their first symptoms in their teen years, but that they may not be recognized as indicative of endometriosis until later in their lives.

Risk factors for endometriosis in adolescents and young women include:

  • congenital abnormalities of the Müllerian duct  (due to increased incidents of retrograde menstruation),
  • first-degree relative with endometriosis, which accounts for approximately 50% of the risk for developing the disease,
  • early onset of menses,
  • prolonged menstruation (> 5 days),
  • short menstrual cycle interval (< 28 days), and
  • early-onset dysmenorrhea.

Studies have also reported associations between endometriosis and exposure to passive smoke during childhood and elevated levels of 2,4-dihydroxybenzophenone (found in sunscreens).

Other risk factors include premature birth, low body mass index, high caffeine or alcohol intake, and acne.

Consumption of soy formula as an infant has been observed to double the risk of endometriosis compared to that in women who were not exposed to dietary soy isoflavones as infants, reported the authors.

Potential protective factors identified:

  • use of oral contraceptives (OCs)
  • regular exercise
  • onset of menses after age 14
  • increased intake of omega-3 fatty acids

Black and Hispanic race compared to white or Asian race may also offer some degree of protection.

Symptoms and signs in adolescents:

Endometriosis lesions often have a different appearance in adolescents than in adults when visualized on laparoscopy: ovarian endometriomas and deep endometrial lesions are more the norm compared to powder-burn lesions seen in adult women.

Ovarian endometriomas are typically filled with “syrup-like chocolate material” and are surrounded by duplicated ovarian parenchyma. They have fibrotic walls and adhesions on the surface, according to the authors and are lined by endometrial epithelium, stroma, and glands. They are typically visualized in the rectovaginal septum, rectum, rectosigmoid colon, bladder, ureter, uterine ligaments, and vagina.

As in adults, the lesions should be staged from minimal disease (Stage 1) to severe disease (Stage 4), based on their size, location, and the types seen, and the extent of adhesions.

Distinguishing primary dysmenorrhea from endometriosis:

Many teens present with dysmenorrhea, which in light of the new information about the development of endometriosis in adolescents and young women should be evaluated to rule out endometriosis.

In adolescents with endometriosis, dysmenorrhea tends to be the first symptom of the disease and increases in severity over time. The pain is both cyclic and acyclic and interferes with school attendance, social activities, and exercise. Teens who are sexually active often report dyspareunia and gastrointestinal distress.

The clinical diagnosis can be verified with pelvic ultrasound and magnetic resonance imaging (MRI), but laparoscopy is the only way to obtain a definitive diagnosis.

The disease is unlikely to resolve spontaneously and is typically treated with nonsteroidal anti-inflammatory drugs, oral contraceptives, and progestin-only contraceptives. Laparoscopy and surgery may be an option for adolescents who fail to respond to medical therapy.

Source/image credit:

http://www.contemporaryobgyn.net/endometriosis/endometriosis-can-affect-adolescents-well-adult-women

 

Visit Us On FacebookVisit Us On Google PlusVisit Us On Linkedin